Atlas Trials

Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation

Clinical trial NCT05498181 · COMPLETED

Trial details

NCT number
NCT05498181
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hemodialysis
Start date
2022-10-11
Primary completion
2026-01-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.